Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic Syndromes

Stopped The primary objective has already been answered with the number of recruited patients.

Conditions

• Myelodysplastic Syndromes
• Acute Myelogenous Leukemia

Interventions

• DRUG: Azacitidine
• DRUG: Lenalidomide

Sponsor

Technische Universität Dresden

Collaborators

• [object Object]